-
1 Comment
Menlo Therapeutics Inc is currently in a long term uptrend where the price is trading 22.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.2.
Menlo Therapeutics Inc's total revenue rose by inf% to $4M since the same quarter in the previous year.
Its net income has dropped by 7.8% to $-23M since the same quarter in the previous year.
Finally, its free cash flow fell by 54.5% to $-25M since the same quarter in the previous year.
Based on the above factors, Menlo Therapeutics Inc gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Biotechnology |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| ISIN | US92941V1008 |
| PE Ratio | None |
|---|---|
| Market Cap | 82M |
| Target Price | 8.56 |
| Dividend Yield | 0.0% |
| Beta | 1.69 |
Menlo Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. It offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older. The company is also developing FMX103, which is in Phase III clinical trials for the treatment of moderate-to-severe papulopustular rosacea in adults; and FCD105, a topical combination foam that is in Phase II clinical trials for the treatment of moderate-to-severe acne vulgaris. In addition, it is developing Serlopitant, a once-daily oral NK1 receptor antagonist, used as a treatment option for pruritus associated with prurigo nodularis. The company was founded in 2003 and is headquartered in Bridgewater, New Jersey.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MNLO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
